Search research articles
Contact Us
Filters
Showing results (81-90 of 508) with videos related to
Page
of 51
Sort By:
Innere Medizin (Heidelberg, Germany)
|
August 24, 2022
[Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat]
E Intert, M Krause, F Hennersdorf, et al.
Clinical Chemistry
|
March 22, 2017
Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls
David P Sonne, Dijana Terzic, Filip K Knop, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Letter: Bif195 for aspirin-induced gastric mucosal damage - More to do in further research. Authors' reply
Nina Løn, Sara Engel, Anders Damholt, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2024
Editorial: The microbiome and gastric mucosal protection in aspirin users-Authors' reply
Nina Løn, Sara Engel, Anders Damholt, et al.
Expert Opinion on Pharmacotherapy
|
August 23, 2021
Treatment of type 2 diabetes in children: what are the specific considerations?
Magnus F G Grøndahl, Jesper Johannesen, Kurt Kristensen, et al.
Medical & Biological Engineering & Computing
|
October 24, 2015
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, K E Kwok, R B Gopaluni, et al.
International Journal of Clinical Practice
|
July 24, 2009
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K B Hansen, F K Knop, J J Holst, et al.
International Journal of Pharmaceutics
|
September 20, 2012
A comparison of quality control methods for active coating processes
D Brock, J A Zeitler, A Funke, et al.
Current Diabetes Reports
|
October 29, 2017
Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
Magnus F Grøndahl, Damien J Keating, Tina Vilsbøll, et al.
Current Opinion in Molecular Therapeutics
|
December 15, 2010
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes
Espen Jimenez-Solem, Mette H Rasmussen, Mikkel Christensen, et al.
Page
of 51
Search research articles
Search
Showing results (81-90 of 508) with videos related to
Sort By:
Page
of 51
Innere Medizin (Heidelberg, Germany)
|
August 24, 2022
[Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat]
E Intert, M Krause, F Hennersdorf, et al.
Clinical Chemistry
|
March 22, 2017
Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls
David P Sonne, Dijana Terzic, Filip K Knop, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2024
Letter: Bif195 for aspirin-induced gastric mucosal damage - More to do in further research. Authors' reply
Nina Løn, Sara Engel, Anders Damholt, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2024
Editorial: The microbiome and gastric mucosal protection in aspirin users-Authors' reply
Nina Løn, Sara Engel, Anders Damholt, et al.
Expert Opinion on Pharmacotherapy
|
August 23, 2021
Treatment of type 2 diabetes in children: what are the specific considerations?
Magnus F G Grøndahl, Jesper Johannesen, Kurt Kristensen, et al.
Medical & Biological Engineering & Computing
|
October 24, 2015
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, K E Kwok, R B Gopaluni, et al.
International Journal of Clinical Practice
|
July 24, 2009
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K B Hansen, F K Knop, J J Holst, et al.
International Journal of Pharmaceutics
|
September 20, 2012
A comparison of quality control methods for active coating processes
D Brock, J A Zeitler, A Funke, et al.
Current Diabetes Reports
|
October 29, 2017
Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
Magnus F Grøndahl, Damien J Keating, Tina Vilsbøll, et al.
Current Opinion in Molecular Therapeutics
|
December 15, 2010
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes
Espen Jimenez-Solem, Mette H Rasmussen, Mikkel Christensen, et al.
Page
of 51